$ Value
$638K
Shares
3,976
Price
$160
Filed
Oct 1
Insider
Name
Chapman Steven Leonard
Title
CEO AND PRESIDENT
CIK
0001711968
Roles
Transaction Details
Transaction Date
2025-10-01
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
154,542
Footnotes
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. | The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 22, 2021. | The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023, as amended on December 2, 2024. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.18 to $159.07 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.2650 to $160.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.28 to $161.2075 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.39 to $161.5750 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | On January 22, 2021, the Reporting Person was granted RSUs covering 75,000 shares of Common Stock which vest in tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. On September 29, 2025, the criteria was satisfied for the vesting of RSUs covering 18,750 shares of Common Stock.
Filing Info
Chapman Steven Leonard's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-10 | NTRA | ▼ | $1.1M |
| 2026-03-09 | NTRA | A | — |
| 2026-03-02 | NTRA | ▼ | $223K |
| 2026-03-02 | NTRA | ▼ | $493K |
| 2026-03-02 | NTRA | ▼ | $73K |
| 2026-02-27 | NTRA | A | — |
| 2026-02-03 | NTRA | ▼ | $1.1M |
| 2026-02-02 | NTRA | ▼ | $1.5M |
| 2026-02-02 | NTRA | ▼ | $9.6M |
| 2026-02-02 | NTRA | ▼ | $4.6M |
Other Insiders at NTRA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| BOTHA ROELOF | — | — | 2026-01-30 |
| ROSENMAN HERM | — | — | 2026-01-30 |
| Williams Brinkley Ruth | — | — | 2026-01-30 |
|
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
|
— | $38.3M | 2026-04-06 |
| Sheena Jonathan | — | $2.4M | 2026-04-17 |
| Baynes Roy D. | — | — | 2026-01-30 |
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
|
— | $2.9M | 2026-03-10 |
| Marcus Gail Boxer | — | — | 2026-01-30 |
|
Chapman Steven Leonard
CEO AND PRESIDENT
|
— | $24.1M | 2026-03-10 |
| Bertagnolli Monica | — | — | 2026-01-30 |
| Chapman Rowan E | — | $23K | 2026-03-13 |
|
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
|
— | $4.5M | 2026-04-01 |
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
|
— | $3.0M | 2026-04-01 |
|
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
|
— | $1.4M | 2026-03-10 |